The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

Susan Kennedy, Maria J. Merino, Sandra M. Swain, Marc E Lippman

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

One hundred four sequential pretherapy and posttherapy breast tissue specimens from 57 patients with locally advanced and metastatic breast cancer were evaluated in an attempt to define the effects of systemic chemotherapeutic agents on the tumors and residual nonneoplastic breast tissue. The patients were treated uniformly at the National Cancer Institute on an experimental protocol combining systemic chemotherapy with attempted hormonal synchronization. Tumors were sampled prior to and following several cycles of chemotherapy to a maximum objective clinical response (average number of cycles, 7). In 38 cases, the posttreatment biopsy was positive for tumor. The most striking histologic change was extreme vacuolization of tumor cells that often resembled histiocytes. Atrophy of the terminal duct lobular unit (TDLU) and atypia of epithelial cells in TDLU and large ducts were also seen. Severe degrees of epithelial atypia occasionally proved to be difficult to distinguish from residual intraductal carcinoma. Breast biopsies were stained with antibodies to cytokeratin, epithelial membrane antigen (EMA), B72.3, lactalbumin, and SP1 using immunoperoxidase techniques. The number of cases showing immunoreactivity with antibodies to cytokeratin, EMA, and B72.3 remained approximately the same before and after therapy, while SP1 expression decreased and lactalbumin expression increased after therapy. Recognition of chemotherapeutic changes in breast tissue is important since systemic chemotherapy plays an important role in the management of breast cancer.

Original languageEnglish
Pages (from-to)192-198
Number of pages7
JournalHuman Pathology
Volume21
Issue number2
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Breast
Lactalbumin
Drug Therapy
Mucin-1
Keratins
Breast Neoplasms
Biopsy
Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Histiocytes
National Cancer Institute (U.S.)
Antibodies
Residual Neoplasm
Immunoenzyme Techniques
Atrophy
Epithelial Cells
Therapeutics
B72.3 antibody

Keywords

  • breast cancer
  • chemotherapy
  • hormone therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. / Kennedy, Susan; Merino, Maria J.; Swain, Sandra M.; Lippman, Marc E.

In: Human Pathology, Vol. 21, No. 2, 01.01.1990, p. 192-198.

Research output: Contribution to journalArticle

Kennedy, Susan ; Merino, Maria J. ; Swain, Sandra M. ; Lippman, Marc E. / The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. In: Human Pathology. 1990 ; Vol. 21, No. 2. pp. 192-198.
@article{3569d886eee145b9a78c724bf5d30943,
title = "The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue",
abstract = "One hundred four sequential pretherapy and posttherapy breast tissue specimens from 57 patients with locally advanced and metastatic breast cancer were evaluated in an attempt to define the effects of systemic chemotherapeutic agents on the tumors and residual nonneoplastic breast tissue. The patients were treated uniformly at the National Cancer Institute on an experimental protocol combining systemic chemotherapy with attempted hormonal synchronization. Tumors were sampled prior to and following several cycles of chemotherapy to a maximum objective clinical response (average number of cycles, 7). In 38 cases, the posttreatment biopsy was positive for tumor. The most striking histologic change was extreme vacuolization of tumor cells that often resembled histiocytes. Atrophy of the terminal duct lobular unit (TDLU) and atypia of epithelial cells in TDLU and large ducts were also seen. Severe degrees of epithelial atypia occasionally proved to be difficult to distinguish from residual intraductal carcinoma. Breast biopsies were stained with antibodies to cytokeratin, epithelial membrane antigen (EMA), B72.3, lactalbumin, and SP1 using immunoperoxidase techniques. The number of cases showing immunoreactivity with antibodies to cytokeratin, EMA, and B72.3 remained approximately the same before and after therapy, while SP1 expression decreased and lactalbumin expression increased after therapy. Recognition of chemotherapeutic changes in breast tissue is important since systemic chemotherapy plays an important role in the management of breast cancer.",
keywords = "breast cancer, chemotherapy, hormone therapy",
author = "Susan Kennedy and Merino, {Maria J.} and Swain, {Sandra M.} and Lippman, {Marc E}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0046-8177(90)90128-R",
language = "English",
volume = "21",
pages = "192--198",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

AU - Kennedy, Susan

AU - Merino, Maria J.

AU - Swain, Sandra M.

AU - Lippman, Marc E

PY - 1990/1/1

Y1 - 1990/1/1

N2 - One hundred four sequential pretherapy and posttherapy breast tissue specimens from 57 patients with locally advanced and metastatic breast cancer were evaluated in an attempt to define the effects of systemic chemotherapeutic agents on the tumors and residual nonneoplastic breast tissue. The patients were treated uniformly at the National Cancer Institute on an experimental protocol combining systemic chemotherapy with attempted hormonal synchronization. Tumors were sampled prior to and following several cycles of chemotherapy to a maximum objective clinical response (average number of cycles, 7). In 38 cases, the posttreatment biopsy was positive for tumor. The most striking histologic change was extreme vacuolization of tumor cells that often resembled histiocytes. Atrophy of the terminal duct lobular unit (TDLU) and atypia of epithelial cells in TDLU and large ducts were also seen. Severe degrees of epithelial atypia occasionally proved to be difficult to distinguish from residual intraductal carcinoma. Breast biopsies were stained with antibodies to cytokeratin, epithelial membrane antigen (EMA), B72.3, lactalbumin, and SP1 using immunoperoxidase techniques. The number of cases showing immunoreactivity with antibodies to cytokeratin, EMA, and B72.3 remained approximately the same before and after therapy, while SP1 expression decreased and lactalbumin expression increased after therapy. Recognition of chemotherapeutic changes in breast tissue is important since systemic chemotherapy plays an important role in the management of breast cancer.

AB - One hundred four sequential pretherapy and posttherapy breast tissue specimens from 57 patients with locally advanced and metastatic breast cancer were evaluated in an attempt to define the effects of systemic chemotherapeutic agents on the tumors and residual nonneoplastic breast tissue. The patients were treated uniformly at the National Cancer Institute on an experimental protocol combining systemic chemotherapy with attempted hormonal synchronization. Tumors were sampled prior to and following several cycles of chemotherapy to a maximum objective clinical response (average number of cycles, 7). In 38 cases, the posttreatment biopsy was positive for tumor. The most striking histologic change was extreme vacuolization of tumor cells that often resembled histiocytes. Atrophy of the terminal duct lobular unit (TDLU) and atypia of epithelial cells in TDLU and large ducts were also seen. Severe degrees of epithelial atypia occasionally proved to be difficult to distinguish from residual intraductal carcinoma. Breast biopsies were stained with antibodies to cytokeratin, epithelial membrane antigen (EMA), B72.3, lactalbumin, and SP1 using immunoperoxidase techniques. The number of cases showing immunoreactivity with antibodies to cytokeratin, EMA, and B72.3 remained approximately the same before and after therapy, while SP1 expression decreased and lactalbumin expression increased after therapy. Recognition of chemotherapeutic changes in breast tissue is important since systemic chemotherapy plays an important role in the management of breast cancer.

KW - breast cancer

KW - chemotherapy

KW - hormone therapy

UR - http://www.scopus.com/inward/record.url?scp=0025254274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025254274&partnerID=8YFLogxK

U2 - 10.1016/0046-8177(90)90128-R

DO - 10.1016/0046-8177(90)90128-R

M3 - Article

C2 - 2155174

AN - SCOPUS:0025254274

VL - 21

SP - 192

EP - 198

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 2

ER -